Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeuroNata-R in ALS
NCT01363401Phase 2Completed
- Sponsor
- Corestemchemon
- Start
- Feb 2011
- Primary completion
- May 2013
- Modality
- Bone Marrow HSCs, Peripheral Blood HSCs
- Countries
- 1
01
Overview
A Phase 2 trial of lenzumestrocel in amyotrophic lateral sclerosis (ALS), sponsored by Corestemchemon. Started Feb 2011; status: completed.
02
Drugs
lenzumestrocel
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT01363401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01363401.